Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction

Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction

Thumbnail Image
Download
Name

thormaehlen-2015-systematic cell.pdf

Size

1.22 MB

Format

Adobe PDF

Checksum (MD5)

a8f9eb9f5a524d59a5531bd0acdfda27

Author(s)
Thormaehlen, Aenne S.
•
Schuberth, Christian
•
Won, Hong-Hee
•
Blattmann, Peter
•
Joggerst-Thomalla, Brigitte
•
Theiss, Susanne
•
Asselta, Rosanna
•
Duga, Stefano
•
Merlini, Piera Angelica
•
Ardissino, Diego
more
Date Issued
February 2015
Journal
PLOS Genetics
Publisher
Public Library of Science
Citation
Thormaehlen, Aenne S., Christian Schuberth, Hong-Hee Won, Peter Blattmann, Brigitte Joggerst-Thomalla, Susanne Theiss, Rosanna Asselta, et al. “Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction.” Edited by Chris Cotsapas. PLoS Genet 11, no. 2 (February 3, 2015): e1004855.
Version
Final published version
Abstract
A fundamental challenge to contemporary genetics is to distinguish rare missense alleles that disrupt protein functions from the majority of alleles neutral on protein activities. High-throughput experimental tools to securely discriminate between disruptive and non-disruptive missense alleles are currently missing. Here we establish a scalable cell-based strategy to profile the biological effects and likely disease relevance of rare missense variants in vitro. We apply this strategy to systematically characterize missense alleles in the low-density lipoprotein receptor (LDLR) gene identified through exome sequencing of 3,235 individuals and exome-chip profiling of 39,186 individuals. Our strategy reliably identifies disruptive missense alleles, and disruptive-allele carriers have higher plasma LDL-cholesterol (LDL-C). Importantly, considering experimental data refined the risk of rare LDLR allele carriers from 4.5- to 25.3-fold for high LDL-C, and from 2.1- to 20-fold for early-onset myocardial infarction. Our study generates proof-of-concept that systematic functional variant profiling may empower rare variant-association studies by orders of magnitude.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/94557
DOI of Published Version
https://doi.org/10.1371/journal.pgen.1004855
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.